Health Secretary Robert F. Kennedy Jr. endorsed the expanded use of RSV vaccines for people 50 through 59 years old who are ...

The new RSV recommendation calls for a single dose of vaccine for adults age 50 to 59 years who are at increased risk of ...

The U.S. Centers for Disease Control and Prevention (CDC) has accepted recommendations from an advisory panel that endorsed ...

MONDAY, July 7, 2025 (HealthDay News) — Adults as young as 50 may now qualify for an RSV vaccine if they have certain health ...

Kennedy selected a new team of medical professionals and scientists who are looking at vaccines are highly qualified.

The US Advisory Committee on Immunization Practices voted in June to stop recommending certain kinds of flu vaccines, a ...

The Trump administration appears to be expanding RSV vaccinations to some adults starting at age 50 instead of 60.

The ACIP is recommending the use of Enflonsia for the prevention of RSV lower respiratory tract disease in infants younger than 8 months.

The Trump administration’s new vaccine advisers endorsed this fall's flu vaccines late last week, but only those that don't ...

The ACIP has recommended that patients only receive seasonal influenza vaccines that do not contain thimerosal.

The FDA delivered two notable approvals for RSV immunization, UroGen overcame a negative advisory committee vote to secure an ...